ADL
FATE icon

Asset Dedication LLC’s Fate Therapeutics FATE Stock Holding History

Asset Dedication LLC’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-55
Closed – – 996
2023
Q4 		$0 Hold
55
– – ﹤0.01% 1003
2023
Q3 		$0 Hold
55
– – ﹤0.01% 1011
2023
Q2 		$0 Hold
55
– – ﹤0.01% 983
2023
Q1 		$0 Hold
55
– – ﹤0.01% 991
2022
Q4 		$1K Hold
55
– – ﹤0.01% 925
2022
Q3 		$1K Hold
55
– – ﹤0.01% 875
2022
Q2 		$1K Hold
55
– – ﹤0.01% 489
2022
Q1 		$2K Hold
55
– – ﹤0.01% 863
2021
Q4 		$3K Hold
55
– – ﹤0.01% 804
2021
Q3 		$3K Hold
55
– – ﹤0.01% 867
2021
Q2 		$5K Buy
+55
New +$4.43K ﹤0.01% 706

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return